Back to search
KCNT1-Related Epilepsy
Clinical trial pipeline · Data from ClinicalTrials.gov
See which KCNT1-Related Epilepsy trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which KCNT1-Related Epilepsy trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This trial will evaluate the safety, tolerability, pharmacokinetics, and clinical activity of ABS-1230 compared with placebo in participants with KCNT1-related…
Study CL1-230815-001 (KANDLE) is a Phase Ib/II, First In Human, multicentre, open-label, multiple ascending dose study to assess the safety, tolerability, pharm…
This first in human trial will evaluate the safety, tolerability, and pharmacokinetics of single ascending doses, multiple ascending doses, and fed and fasted d…